Abstract
At each step of its life-cycle, human immunodeficiency virus type 1 (HIV-1) interacts with cellular proteins. In some cases, such as the cellular cytidine deaminase APOBEC3G, cellular proteins repress HIV-1 replication. In other cases, cellular proteins serve as essential co-factors, and inhibition of their function blocks HIV-1 replication. This review explores the opportunities for anti-HIV-1 therapy that stem from the recent discoveries that cellular proteins, which are involved in double-strand break DNA repair, are also required for completion of integration of HIV-1 DNA into host cell DNA.
Keywords: non-homologous end joining, post-integration repair, integration, ATR, ATM, DNA-PK, HIV-1
Current HIV Research
Title: DNA Repair in HIV-1 Infection: A Case for Inhibitors of Cellular Co-Factors?
Volume: 4 Issue: 4
Author(s): Rene Daniel
Affiliation:
Keywords: non-homologous end joining, post-integration repair, integration, ATR, ATM, DNA-PK, HIV-1
Abstract: At each step of its life-cycle, human immunodeficiency virus type 1 (HIV-1) interacts with cellular proteins. In some cases, such as the cellular cytidine deaminase APOBEC3G, cellular proteins repress HIV-1 replication. In other cases, cellular proteins serve as essential co-factors, and inhibition of their function blocks HIV-1 replication. This review explores the opportunities for anti-HIV-1 therapy that stem from the recent discoveries that cellular proteins, which are involved in double-strand break DNA repair, are also required for completion of integration of HIV-1 DNA into host cell DNA.
Export Options
About this article
Cite this article as:
Daniel Rene, DNA Repair in HIV-1 Infection: A Case for Inhibitors of Cellular Co-Factors?, Current HIV Research 2006; 4 (4) . https://dx.doi.org/10.2174/157016206778560027
DOI https://dx.doi.org/10.2174/157016206778560027 |
Print ISSN 1570-162X |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4251 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Resveratrol and Clinical Trials: The Crossroad from In Vitro Studies to Human Evidence
Current Pharmaceutical Design Metalloproteinases and Metalloproteinase Inhibitors in Age-Related Diseases
Current Pharmaceutical Design Monochloramine Use for Prevention of Legionella in Hospital Water Systems.
Infectious Disorders - Drug Targets Biomolecules for Removal of Heavy Metal
Recent Patents on Biotechnology The Nature of Protein Domain Evolution: Shaping the Interaction Network
Current Genomics Heat Shock Proteins; An Overview
Current Pharmaceutical Biotechnology Use of Diuretics in Women for Management of Hypertension
Current Hypertension Reviews Actinic Keratosis Pathogenesis Update and New Patents
Recent Patents on Inflammation & Allergy Drug Discovery Anti-VEGF Molecules for the Management of Diabetic Macular Edema
Current Pharmaceutical Design Isoenzyme Selective Phosphoinositide 3-Kinase Inhibition: What do the Stones Kill?
Current Signal Transduction Therapy Antioxidant Activity of Galantamine and Some of its Derivatives
Current Medicinal Chemistry Rationalizing the Study of Plants for the Treatment of Oral Pain
Current Chemical Biology Target-oriented Mechanisms of Novel Herbal Therapeutics in the Chemotherapy of Gastrointestinal Cancer and Inflammation
Current Pharmaceutical Design A Review on the Nutritional Aspects of Wild Edible Plants
Current Traditional Medicine Efficacy and Safety of H1-Antihistamines: An Update
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Perspective of Cyclin-dependent kinase 9 (CDK9) as a Drug Target
Current Pharmaceutical Design Strategies for Novel Therapeutic Approaches Targeting Cytokines and Signaling Pathways of Osteoclasto- and Osteoblastogenesis in the Fight Against Immune-Mediated Bone and Joint Diseases
Current Medicinal Chemistry Sirtuin3 in Neurological Disorders
Current Drug Research Reviews Therapeutic Implications of Tocilizumab, A Humanized Anti-Interleukin-6 Receptor Antibody, for Various Immune-Mediated Diseases: An Update Review
Current Rheumatology Reviews Patent Selections:
Recent Patents on Anti-Cancer Drug Discovery